High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing
about
Low penetrance of a SDHB mutation in a large Dutch paraganglioma family15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potentialPhysiological consequences of complex II inhibition for aging, disease, and the mKATP channelAn update on the genetics of pheochromocytomaPharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapyGenotype-Phenotype Correlation in Patients With Germline Mutations of VHL, RET, SDHB, and SDHD Genes: Thai Experience.Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomasAnti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literatureNF-κB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model.SDH-related pheochromocytoma and paraganglioma.Solid tumors associated with multiple endocrine neoplasias.New imaging approaches to phaeochromocytomas and paragangliomas.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentThe size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort studyClinical experiences of pheochromocytoma in Korea.Metastatic paraganglioma.Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literature.An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers.Genetic testing for pheochromocytoma.Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromesMeasurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.Metastatic pheochromocytoma: does the size and age matter?Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutationsSuperiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.The genetic basis of pheochromocytoma and paraganglioma: implications for managementUpdated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma.Phaeochromocytoma: a catecholamine and oxidative stress disorder.Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl.The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancerFalse-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.Disentangling of Malignancy from Benign Pheochromocytomas/ParagangliomasStructural basis for malfunction in complex II.Pheochromocytoma - update on disease management.Clinical aspects of SDHx-related pheochromocytoma and paragangliomaSuccessful chemotherapy of hepatic metastases in a case of succinate dehydrogenase subunit B-related paraganglioma.
P2860
Q21261505-DB21C236-92F1-4C3F-95DA-9291338E21F4Q26798384-EB54E30C-C4D7-4783-AA3F-98B1E26DE47DQ26865711-F8E76529-53F2-4D33-B76A-875F3D9020EFQ27002338-941F0A78-1ECF-4E2F-B2FB-2AC814D3BECEQ27024087-DB54E258-1629-4BBC-8F6A-8CD1A2271DB2Q28477147-90477BB8-449E-448E-937C-4F32C32D73DDQ33602864-AC460AC8-3C09-4AF5-8B94-4BE555E86312Q33637176-6746D06D-598D-4139-89EA-46FA8F731F5DQ33638286-659941E6-A487-4B7C-9233-A828600E017FQ34029349-8BE0AEFF-6E2F-4229-AAED-7F75AF94CDEBQ34038994-A5D4F7AE-5B7E-4140-9AA0-EB3F25E1F975Q34125978-1A8917C2-B030-4B68-B43B-4781CEFC8FFEQ34213017-EB5F89A6-A0C6-45ED-BB3C-F0F5F4DAAFCEQ34255457-F57BDF5D-F111-4E43-85EE-5AD8AE5856A3Q34410500-69A63865-FC7B-487E-B9F0-2DD300A5A021Q34469783-422F8D97-95DA-4B80-80E9-3504499CECAEQ34474643-77EC47C7-5F3D-406A-A718-EFAA66873C4AQ34480015-35A87219-B8DD-4549-985B-FE72DB21FAD5Q34541335-21E4B4A8-4EEF-483D-9290-BE28629DB0CAQ34627182-E1AEB926-DD2B-4ADE-8725-C7791BE85E8CQ34700634-D3CBB1D9-A5F8-4EDD-84BD-08A3B8C16618Q34921220-64EA2DB3-362A-4950-902C-DE126A284D54Q35185252-2437C390-83B2-42AE-AF6F-710D075326E4Q35190348-B6611EDA-1CB6-44E9-953A-8F41D89CEC81Q35206646-1F818F7A-1AFC-476B-B615-B7E007146916Q35323457-6A1ED3C8-53BD-4D1E-A873-971A9A4770E3Q35527336-9E815FA2-0E81-4ADF-B6F0-975342B9E692Q36021577-A43C4D22-880B-42EE-BD41-58B46640CB45Q36024376-7E98A3D3-9211-46B8-AFE5-387176D129B6Q36067684-3956712C-481A-476B-B3EB-590B50D955F9Q36125143-DDCEF7C4-8932-4992-BB93-3A646166DC8BQ36149357-B478FF2E-F16B-4292-8FE5-A7D285DBA855Q36158527-CEB2B32B-7BBD-4555-A507-DC7997C23F66Q36164034-2A76EB19-C5EE-408E-8691-0D85ACC68424Q36167038-4C6A0EF6-DECA-457A-8985-AEB94C96CBDDQ36228294-310F6919-FA52-4EFA-A81B-10576B7B4E04Q36318828-838B0304-59D7-4DC1-8492-1EF469429261Q36328071-8F8631CA-D584-444F-B8C9-CB1021E69408Q36458394-861BC766-DDB7-41CC-997E-B028AF2B66C8Q36463104-FB574427-5490-4146-B1AD-1B56B3F23F8A
P2860
High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
High frequency of SDHB germlin ...... plications for genetic testing
@ast
High frequency of SDHB germlin ...... plications for genetic testing
@en
High frequency of SDHB germlin ...... plications for genetic testing
@nl
type
label
High frequency of SDHB germlin ...... plications for genetic testing
@ast
High frequency of SDHB germlin ...... plications for genetic testing
@en
High frequency of SDHB germlin ...... plications for genetic testing
@nl
prefLabel
High frequency of SDHB germlin ...... plications for genetic testing
@ast
High frequency of SDHB germlin ...... plications for genetic testing
@en
High frequency of SDHB germlin ...... plications for genetic testing
@nl
P2093
P3181
P356
P1476
High frequency of SDHB germlin ...... plications for genetic testing
@en
P2093
Frederieke M Brouwers
Graeme Eisenhofer
Jeffrey A Kant
Jessica J Tao
Karen T Adams
W Marston Linehan
P304
P3181
P356
10.1210/JC.2006-0423
P407
P50
P577
2006-11-01T00:00:00Z